In-Vitro Diagnostics Quality Control Market Share

Statistics for the 2023 & 2024 In-Vitro Diagnostics Quality Control market share, created by Mordor Intelligence™ Industry Reports. In-Vitro Diagnostics Quality Control share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research In Vitro Diagnostic Devices Research IVD Quality Control Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of In-Vitro Diagnostics Quality Control Industry

The in-vitro diagnostics quality controls market is moderately competitive and consists of several major players. Some companies are expanding their market position by adopting various strategies such as acquisitions and mergers, while others are developing new methods for the quality check to maintain their market share. Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, SeraCare Life Sciences Inc., bioMerieux Inc., and ZeptoMetrix Corporation are some of the companies currently dominating the market.

In-Vitro Diagnostics Quality Control Market Leaders

  1. Bio-Rad Laboratories Inc

  2. bioMerieux Inc

  3. F. Hoffmann-La Roche AG

  4. SeraCare Life Sciences Inc

  5. ZeptoMetrix Corporation

*Disclaimer: Major Players sorted in no particular order

In-Vitro Diagnostics Quality Control Market Concentration

In Vitro Diagnostics Quality Control Market Report Snapshots

In vitro Diagnostics Quality Control Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)